Global Cancer Tumor Profiling Market Size
Healthcare Services

Global Cancer Tumor Profiling Market Size, Forecasts, And Opportunities – Includes Cancer Tumor Profiling Market Analysis

Learn about the global cancer tumor profiling market through The Business Research Company, which provides information on cancer tumor profiling market size, cancer tumor profiling market drivers and restraints, cancer tumor profiling market players, the COVID-19 impact on the cancer tumor profiling market, and more.

 

The global cancer tumor profiling market size is expected to grow from $8.16 billion in 2021 to $9.58 billion in 2022 at a compound annual growth rate (CAGR) of 17.5%. The global cancer tumor profiling market size is expected to grow to $15.96 billion in 2026 at a CAGR of 13.6%.

 

The increasing incidences of cancer across the globe are expected to propel the growth of cancer and tumor profiling market going forward.

 

Request A Sample For The Global Cancer Tumor Profiling Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6053&type=smp

 

Global Cancer Tumor Profiling Market Size
Global Cancer Tumor Profiling Market Size

The cancer tumor profiling market consists of sales of cancer tumor profiling technologies by entities (organization, partnership, sole traders) that refer to a laboratory test that examines a sample of tumor tissue for specific genes or gene mutations (changes), proteins, or other biomarkers. Tumor profiling can help with treatment planning as well as predicting if cancer will recur or spread to other parts of the body.

 

Global Cancer Tumor Profiling Market Segments Include:

By Cancer Type: Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Ovarian Cancer, Stomach Cancer, Pancreatic Cancer, Thyroid Cancer, Others

By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), In Situ Hybridization (ISH), Microarray, Others

By Process Type: Genomics, Proteomics, Epigenetics, Metabolomics, Others

By Application: Personalized Medicine, Diagnostics, Biomarker Discovery, Prognostics, Research Applications

By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America was the largest region in cancer and tumor profiling market in 2021.

 

The increasing research and development activities have emerged as the key trend gaining popularity in the cancer and tumor profiling market. Major companies operating in the cancer and tumor profiling sector are focused on research and development activities to meet consumer demand and reinforce their position.

 

TBRC’s Cancer Tumor Profiling Market Report Covers:

Major Market Players: F. Hoffmann-La Roche Ltd, Caris Life Sciences, Thermo Fisher Scientific Inc., Illumina Inc., QIAGEN, Ribomed Biotechnologies Inc., HTG Molecular Diagnostics Inc., NanoString, NeoGenomics Laboratories, Lucence Health Inc., ACT Genomics Co. LTD, Strand Life Sciences, IMB Dx Inc., Exact Sciences Corporation (Genomic Health Inc.), Guardant Health, and Foundation Medicine Inc.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Time Series: Five years historic (2016-21) and ten years forecast (2022-2026-2031)

 

The Cancer Tumor Profiling Global Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026 is one of a series of new reports from The Business Research Company that provides cancer tumor profiling market overviews, analyzes and forecasts market size, share, cancer tumor profiling market players, cancer tumor profiling market segments and geographies, leading competitor revenues, profiles and market shares.

 

TBRC’s cancer tumor profiling market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

 

Here Is A List Of Similar Reports From The Business Research Company:

Oncology Devices Global Market Report 2022

Oncology Molecular Diagnostics Global Market Report 2022

Oncology Drugs Global Market Report 2022

 

Interested To Know More About The Business Research Company?

The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

 

Read More About Us At https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

 

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

 

Found this article helpful? Share it on:

Leave a Reply

Your email address will not be published. Required fields are marked *